Profilnine is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of Profilnine is Factor IX complex (human).
Profilnine is a clotting factor. Clotting factors work by supplying proteins missing in people with hemophilia.
How do I take it?
Prescribing information states that Profilnine is given as an intravenous injection.
Profilnine comes as a powder that must be reconstituted before injection.
The FDA-approved label for Profilnine lists common side effects including chills, nausea, vomiting, flushed skin, a tingling sensation, and pain at the injection site.
Rare but serious side effects listed for Profilnine include severe hypersensitivity reactions and the transmission of infections.
For more details about this treatment, visit:
Profilnine – Grifols
Treatment of Hemophilia – Hemophilia Federation of America